Malawi Clinical Trials

• Assessing the Efficacy of Four Drug Combinations as the Next First-Line Therapy for Uncomplicated Malaria in Malawi
  ClinicalTrials.gov Identifier: NCT00164710 - Active, not recruiting
  Malaria, Falciparum
  
• Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi
  ClinicalTrials.gov Identifier: NCT00164359 - Active, not recruiting
  Malaria, Falciparum
  
• Chloroquine Alone or in Combination for Malaria in Children in Malawi
  ClinicalTrials.gov Identifier: NCT00379821 - Recruiting
  Plasmodium Falciparum Malaria
  
• CQSP in Malawi: Chloroquine and Sulfadoxine-Pyrimethamine Efficacy for the Treatment of Malaria in Malawi.
  ClinicalTrials.gov Identifier: NCT00125489 - Completed
  Malaria
  
• Immune Responses to BCG Vaccination in Malawi and the UK
  ClinicalTrials.gov Identifier: NCT00241657 - Completed
  Immunity, Cellular; Hypersensitivity, Delayed Type
  
• Intravaginal Treatment of Distrubances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi
  ClinicalTrials.gov Identifier: NCT00140764 - Completed
  Bacterial Vaginosis; Trichomonas Vaginitis; Genitourinary symptoms
  
• Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: Malawi
  ClinicalTrials.gov Identifier: NCT00126906 - Completed
  Malaria, Falciparum; HIV Infections